Who We Are

About Mitralign

Mitralign is a venture backed privately held company located in a suburb of Boston, MA. Founded in 2003, the company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus through a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening,

Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.

Mission Statement

Mitralign is dedicated to improving the quality of life for patients with functional mitral regurgitation by developing catheter based solution which rivals surgical annuloplasty.